🇺🇸 FDA
Patent

US 9567345

Pharmaceutically active pyrazolo-triazine derivatives

granted A61PA61P1/04A61P1/16

Quick answer

US patent 9567345 (Pharmaceutically active pyrazolo-triazine derivatives) held by Lead Discovery Center GmbH expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/00, A61P11/02